Holen Sie sich die Stockscreener-App
34.37
2.55%
-0.90
Schlusskurs vom Vortag:
$35.27
Offen:
$35.58
24-Stunden-Volumen:
100.57K
Relative Volume:
0.49
Marktkapitalisierung:
$648.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.49M
KGV:
-7.7115
EPS:
-4.457
Netto-Cashflow:
$-60.29M
1W Leistung:
-9.39%
1M Leistung:
+22.53%
6M Leistung:
+67.17%
1J Leistung:
+58.24%
1-Tages-Spanne:
$33.86
$35.58
1-Wochen-Bereich:
$33.86
$39.53
52-Wochen-Spanne:
$14.38
$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
34.37 | 648.53M | 0 | -83.49M | -60.29M | -4.457 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | Stifel | Buy |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Price to earnings forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation - Moomoo
We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely - Sahm
MSN Money - MSN
achievement unlocked! - Moomoo
Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan - Stock Titan
Form 144 TECTONIC THERAPEUTIC For: 30 June By Investing.com - Investing.com Nigeria
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Tectonic Therapeutic (TECX) Stages a 3% Rally: Key Levels to Watch for Continued MomentumEnding Diagonal - dars.gov.et
Tectonic Therapeutic Inc Actuals & Estimates (NASDAQ:TECX) - TradingView
TECX Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Tectonic Therapeutic Inc For: 23 June By Investing.com - Investing.com South Africa
Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs - Stock Titan
TECXTectonic Therapeutic Inc Short Interest - Finviz
Tectonic Therapeutic Inc (TECX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TECX Q1 2026 Earnings: Deeper-than-Expected Loss Highlights Pre-Revenue StageEarnings Cycle Report - dars.gov.et
Tectonic Therapeutic Inc (TECX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tectonic Therapeutic Inc (TECX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tectonic Therapeutic Inc (TECX) Institutional Confidence - TradingKey
Tectonic Therapeutic Inc (TECX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tectonic Therapeutic Inc (TECX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic Inc (TECX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Tectonic Therapeutic Inc (TECX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tectonic Therapeutic (TECX) CFO receives 7,500 performance stock options at $16.80 - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Tectonic Therapeutic (TECX) - The Globe and Mail
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $101 - Moomoo
Tectonic completes enrollment in TX45 pulmonary hypertension trial - Investing.com UK
Tectonic completes enrollment in TX45 pulmonary hypertension trial By Investing.com - Investing.com Australia
Tectonic Therapeutic Completes Enrollment in Key TX45 Trial - TipRanks
Tectonic Therapeutic (TECX) finishes TX45 Phase 2 APEX enrollment, sets early Q1 2027 data - Stock Titan
Director at Tectonic Therapeutic (TECX) awarded 10,200 options - Stock Titan
Director at Tectonic Therapeutic (TECX) granted 10,200 stock options - Stock Titan
Tectonic Therapeutic (TECX) director receives 10,200 stock options at $28.56 - Stock Titan
Director at Tectonic Therapeutic (TECX) receives 10,200 stock options expiring 2036 - Stock Titan
Tectonic Therapeutic (TECX) awards 20,400 stock options to director - Stock Titan
New Tectonic Therapeutic (TECX) director Jessica Chutter files initial Form 3 - Stock Titan
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - The Manila Times
Tectonic Therapeutic (TECX) Slides 2.61% as Biotech Sector Faces PressureEquity Put Call - newsline.com
TECX: All proposals passed, with directors reelected and auditor ratified; no shareholder questions - TradingView
Tectonic Therapeutic Inc. (TECX) Advances 2.50% as Shares Test Resistance Near $30.59Continuation Pattern Picks - newsline.com
Tectonic Therapeutic (TECX) Posts 2.5% Gain as Biotech Sentiment ImprovesWyckoff Spring - newsline.com
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Tectonic Therapeutic (TECX) Surges 4.65%: Strong Momentum or Technical Resistance Ahead?Triple EMA - The Legal Advocate
Tectonic Therapeutic (TECX) Slides 1.74% as Biotech Sector Headwinds PersistWeak Sell Signals - The Legal Advocate
Tectonic Therapeutic Inc. (TECX) Slips 2.53% as Biotech Sentiment Weighs on SharesSocial Sentiment - dars.gov.et
Raymond James upgrades Tectonic Therapeutic (TECX) - MSN
TECX Upgraded by Raymond James -- Price Target Raised to $81.00 - GuruFocus
Tectonic Therapeutic (TECX) Rallies 3.76% as Biotech Momentum Builds – Key Levels to WatchTrend Following Picks - The Legal Advocate
Tectonic Therapeutic Shares Rise After Raymond James Upgrade - Moomoo
TECX Q1 2026 Earnings: Loss Widens but Pipeline Optimism Drives Stock HigherAnalyst Drop Coverage - The Legal Advocate
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):